Low HERV-K(C4) copy number is associated with type 1 diabetes

Diabetes

Volumn 63, Issue 5, 2014, Pages 1789-1795

  Mason, Mike J ^a   Speake, Cate ^a   Gersuk, Vivian H ^a   Nguyen, Quynh Anh ^a   O'Brien, Kimberly K ^a   Odegard, Jared M ^a   Buckner, Jane H ^a   Greenbaum, Carla J ^a   Chaussabel, Damien ^a   Nepom, Gerald T ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLELES; CHILD; COMPLEMENT C4; DIABETES MELLITUS, TYPE 1; DNA COPY NUMBER VARIATIONS; ENDOGENOUS RETROVIRUSES; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMORPHISM, GENETIC;

EID: 84899126426     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1382     Document Type: Article

References (25)

1. Nepom GT. The major histocompatibility complex. In Harrison's Principles of Internal Medicine. 18th ed. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, Eds. New York, McGraw-Hill Medical Publishing Division, 2012, p. 2685-2694
2. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what's next? Diabetes 2010;59:1561-1571
3. Sheehy MJ, Scharf SJ, Rowe JR, et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989;83:830-835 (Pubitemid 19080613)
4. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525
5. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084-1092
6. Raum D, Awdeh Z, Yunis EJ, Alper CA, Gabbay KH. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest 1984;74:449-454 (Pubitemid 14053992)
7. Price P, Witt C, Allcock R, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167:257-274 (Pubitemid 29178987)
8. Bánlaki Z, Doleschall M, Rajczy K, Fust G, Szilágyi A. Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes. Genes Immun 2012;13:530-535
9. Barba G, Rittner C, Schneider PM. Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression. J Clin Invest 1993;91:1681-1686 (Pubitemid 23127373)
10. Marcelli-Barge A, Poirier JC, Chantome R, Deschamps I, Hors J, Colombani J. Marked shortage of C4B DNA polymorphism among insulin-dependent diabetic patients. Res Immunol 1990;141:117-128 (Pubitemid 20187078)
11. Jenhani F, Bardi R, Gorgi Y, Ayed K, Jeddi M. C4 polymorphism in multiplex families with insulin dependent diabetes in the Tunisian population: standard C4 typing methods and RFLP analysis. J Autoimmun 1992;5:149-160
12. Bertrams J, Hintzen U, Schlicht V, et al. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Immunobiology 1984;166:335-344 (Pubitemid 14053733)
13. McCluskey J, McCann VJ, Kay PH, et al. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia 1983;24:162-165 (Pubitemid 13147819)
14. Tassabehji M, Strachan T, Anderson M, Campbell RD, Collier S, Lako M. Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. Nucleic Acids Res 1994;22:5211-5217
15. Wouters D, van Schouwenburg P, van der Horst A, et al. High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. Mol Immunol 2009;46:592-600
16. Hohn O, Hanke K, Bannert N. HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front Oncol 2013;3:246
17. Shin W, Lee J, Son S-Y, Ahn K, Kim H-S, Han K. Human-specific HERV-K insertion causes genomic variations in the human genome. PLoS ONE 2013;8:e60605
18. Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004;56:321-332 (Pubitemid 39222763)
19. Schneider PM, Witzel-Schlömp K, Rittner C, Zhang L. The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics 2001;53:1-9 (Pubitemid 32209406)
20. Wu YL, Savelli SL, Yang Y, et al. Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J Immunol 2007;179:3012-3025
21. Gersuk VH, Nepom GT. A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLA-DQB1*0602. Tissue Antigens 2009;73:335-340
22. Gersuk VH, Nepom GT. A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04. J Immunol Methods 2006;317:64-70 (Pubitemid 44809203)
23. Kwok WW, Schwarz D, Nepom BS, Hock RA, Thurtle PS, Nepom GT. HLA-DQ molecules form alpha-beta heterodimers of mixed allotype. J Immunol 1988;141:3123-3127
24. Alper CA, Awdeh ZL, Yunis EJ. Complotypes, extended haplotypes, male segregation distortion, and disease markers. Hum Immunol 1986;15:366-373 (Pubitemid 16127318)
25. Skanes VM, Barnard J, Farid N, et al. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Mol Biol Med 1986;3:143-157